Skip to main content

Source: www.health.economictimes.indiatimes.com

With an objective of making quality generic medicines available at affordable prices to all, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India in November, 2008. From Oct 31,2022 around 8819 Janaushadhi Kendras are functional across the country and cover over 1759 drugs and 280 surgical items. This scheme not only can provide a self-employment opportunity but also provide financial assistance to various groups of the society. 

The Centre has approved inviting online applications for opening new Jan Aushadhi Kendras (JAK) in 651 districts in different states/UTs. The proposal will be sent by the Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). 

Under this scheme, there are already more than 9,000 JAKs functional across the country. The government has set a target to increase the number of Jan Aushadhi Kendras to 10,000 by March 2024. 

The product basket of PMBJP comprises 1,759 medicines and 280 surgical devices covering all major therapeutic groups. PMBJP was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilisers, in 2008 with an objective of making quality generic medicines available at affordable prices to all.

This scheme provides an opportunity of self-employment with sustainable and regular earnings. Under PMBJP, an incentive of Rs five lakhs is provided to every JAK as financial assistance and one-time additional incentive of Rs two lakhs (as reimbursement for IT and infra expenditure) is provided to each JAK opened in the Northeastern states, Himalayan areas, island territories and backward areas identified as aspirational districts by NITI Ayog, or if opened by women entrepreneurs, ex-servicemen, divyangs, SCs & STs.

InnoHEALTH magazine digital team

Author InnoHEALTH magazine digital team

More posts by InnoHEALTH magazine digital team

Leave a Reply